This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Panocell-10 Ficin-Treated (2015-11-19)
- Starting date:
- November 19, 2015
- Type of communication:
- Medical Device Recall
- Subcategory:
- Medical Device
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Medical Devices
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-56206
Affected Products
Panocell-10 Ficin-Treated
Reason
Immucor Inc. (manufacturer of the device) notified dominion biologicals limited of the intent to initiate a market withdrawal of cell 4 included in the Panocell-10 Ficin-treated, Lot 38324-E. Cell 4 (DONORD1377) on this panel, is listed as S+S- on the master list. In response to a report of unexpected negative reactivity on untreated cell 4, we have reproduced the customer's reported results. Cell 4 has demonstrated reactivity varying from negative to 3+ using different sources of anti-S. Cell 4 is one of four S+ red blood cells on this panel: cells 2, 7 and 9 are also s+. Cell 4 is the only s+s- cell on this panel.
Affected products
Panocell-10 Ficin-Treated
Lot or serial number
38324-E
Model or catalog number
0002385
Companies
- Manufacturer
-
Immucor Inc.
3130 Gateway Drive, P.O. Box 5625
Norcross
30091-5625
Georgia
UNITED STATES